Why Drug Companies Are Racing to Target NRF2, The Cell’s Master Stress Switch
NRF2 acts as your cellular fire chief, coordinating emergency responses when cells face oxidative stress or toxic threats. Pharmaceutical companies are investing hundreds of millions to develop drugs targeting this ancient molecular switch that controls cellular resilience.